Aurinia Pharmaceuticals's total assets for Q1 2025 were $504.85M, a decrease of -8.32% from the previous quarter. AUPH total liabilities were $154.66M for the fiscal quarter, a -10.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.